C57BL/6N-Tg(Nr2f2-cre/ERT2)40Ics/Ics
Status | Available to order |
EMMA ID | EM:15558 |
International strain name | C57BL/6N-Tg(Nr2f2-cre/ERT2)40Ics/Ics |
Alternative name | Tg(Nr2f2-cre/ERT2)40.ICS |
Strain type | Transgenic Strains |
Allele/Transgene symbol | Tg(Nr2f2-cre/ERT2)40.ICS |
Gene/Transgene symbol | Tg(Nr2f2-cre/ERT2)40.ICS |
Information from provider
Provider | ICS, Institut Clinique de la Souris |
Provider affiliation | ICS, Institut Clinique de la Souris |
Genetic information | The line was obtained by microinjection of a circular murine BAC transgene (RP23-109L9), previously modified by recombineering at the ATG of the Nrf2f2 gene of a Cre-F3-ERT2-F3 dual cassette followed by a roxed PGK-Tn5-Kana/NeoR cassette. The genetic background of the fertilized oocytes was C57BL/6N. The line was then maintained in a C57BL/6N genetic background. The roxed PGK-Tn-Kana/NeoR cassette was not removed. The subline 40 was analyzed and cryopreserved. The number of transgenic copies integrated into the genome was estimated to be one per ddPCR. The corresponding integration site was not searched. The expression of cre mRNA was observed at low level in heart, ovary and uterus (respectively 5, 1 and 2% of Nr2f2 endogenous expression). For detailed information on the genetic description of this strain, please have a look at this report. |
Phenotypic information | Homozygous:NAHeterozygous:NA |
Breeding history | C57BL/6N inbred (3 generations). |
References | None available |
Homozygous fertile | not known |
Homozygous viable | not known |
Homozygous matings required | no |
Immunocompromised | no |
Information from EMMA
Archiving centre | ICS, Institut Clinique de la Souris, Illkirch-Graffenstaden, France |
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).